Renaissance Capital logo

Talaris Therapeutics Priced, Nasdaq: TALS

Phase 3 biotech developing allogeneic cell therapies for organ transplant recipients.

Industry: Health Care

Latest Trade: $16.66 -0.34 (-2.0%)

First Day Return: n/a

Return from IPO: 0.0%

Industry: Health Care

We are a late-clinical stage, cell therapy company developing an innovative method of allogeneic hematopoietic stem cell transplantation (allo-HSCT) that we believe has the potential to transform the standard of care in solid organ transplantation, certain severe autoimmune diseases and certain severe non-malignant blood, immune and metabolic disorders. In the organ transplant setting, which is our initial focus, we believe our proprietary therapeutic approach, which we call Facilitated Allo-HSCT Therapy, could prevent organ rejection without the morbidity and mortality that has been associated with the use of lifelong anti-rejection medicines, also known as chronic immunosuppression. Beyond the organ transplant setting, our Facilitated Allo-HSCT Therapy also has the potential to treat a range of severe autoimmune diseases and severe non-malignant blood, immune and metabolic disorders, in each case with potential for similar outcomes to what has previously been observed with HSCT, while mitigating the toxicities, morbidities and extended hospital stay associated with the conditioning regimen typically required by HSCT. We believe that our target indications, individually and collectively, represent a significant unmet need and commercial opportunity.
more less
IPO News for Talaris Therapeutics
more
IPO Data
IPO File Date 04/16/2021
Offer Price $17.00
Price Range $16.00 - $18.00
Offer Shares (mm) 8.8
Deal Size ($mm) $150
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
IPO Data
IPO Date 05/06/2021
Offer Price $17.00
Price Range $16.00 - $18.00
Offer Shares (mm) 8.8
Deal Size ($mm) $150
Lock-Up Date IPO Pro Only
Street Research IPO Pro Only
Underwriters
more
Company Data
Headquarters Louisville, KY
Founded 2002
Employees 82
Website www.talaristx.com